1. Home
  2. SOAR vs TOVX Comparison

SOAR vs TOVX Comparison

Compare SOAR & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Volato Group Inc.

SOAR

Volato Group Inc.

HOLD

Current Price

$0.23

Market Cap

11.3M

Sector

Finance

ML Signal

HOLD

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.19

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOAR
TOVX
Founded
2021
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
11.1M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
SOAR
TOVX
Price
$0.23
$0.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $2.50
AVG Volume (30 Days)
★ 7.4M
398.2K
Earning Date
11-12-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 104.83
89.07
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.16
52 Week High
$1.75
$0.49

Technical Indicators

Market Signals
Indicator
SOAR
TOVX
Relative Strength Index (RSI) 47.38 34.37
Support Level $0.18 $0.17
Resistance Level $0.26 $0.25
Average True Range (ATR) 0.02 0.01
MACD -0.01 -0.00
Stochastic Oscillator 15.14 5.53

Price Performance

Historical Comparison
SOAR
TOVX

About SOAR Volato Group Inc.

Volato Group Inc is an aviation technology company that connects travelers to private, on-demand flight access and develops proprietary software platforms for enterprise and operational applications. The company operates in a single operating and reportable segment, private aviation services. It operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: